Compounds > levodopa

Page last updated: 2024-08-17

levodopa and buthionine sulfoximine

levodopa has been researched along with buthionine sulfoximine in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (22.22)	18.7374
1990's	3 (33.33)	18.2507
2000's	3 (33.33)	29.6817
2010's	1 (11.11)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J	1
Bartsch, O; Busse, E; Kornhuber, B	1
Meadows, GG; Thrall, BD	1
Favier, D; Kable, EP; Parsons, PG	1
Clavier, RM; Foulks, JG; Godin, DV; Ito, M; Perry, TL; Wall, RA; Yong, VW	1
Cohen, G; Han, SK; Mytilineou, C	1
Canals, S; Casarejos, MJ; de Bernardo, S; Handler, A; Mena, MA; Rodríguez-Martín, E	1
Casarejos, MJ; Correa, C; García de Yébenes, J; Mena, MA; Menéndez, J; Rodríguez-Navarro, JA; Solano, RM	1
Alonso-Alvarez, C; Galván, I; Solano, F; Wakamatsu, K	1

Other Studies

9 other study(ies) available for levodopa and buthionine sulfoximine

Article	Year
Chemical genetics reveals a complex functional ground state of neural stem cells. Nature chemical biology, 2007, Volume: 3, Issue:5 Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells	2007
Non-myelotoxic antitumour effects of L-dopa, buthionine sulphoximine and tamoxifen on neuroblastoma cells in vitro and in vivo. Journal of cancer research and clinical oncology, 1991, Volume: 117, Issue:5 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Antineoplastic Agents; Buthionine Sulfoximine; Cell Survival; Cyclic AMP; Glutathione; Humans; Levodopa; Male; Methionine Sulfoximine; Mice; Mice, Nude; Monophenol Monooxygenase; Neuroblastoma; Tamoxifen; Tumor Cells, Cultured	1991
Effect of L-dopa methylester and glutathione depletion on murine B16BL6 melanoma growth in vitro. The Journal of investigative dermatology, 1991, Volume: 97, Issue:6 Topics: Animals; Buthionine Sulfoximine; Cell Division; Cell Transformation, Neoplastic; Glutathione; Levodopa; Melanoma, Experimental; Methionine Sulfoximine; Mice	1991
Sensitivity of human melanoma cells to L-dopa and DL-buthionine (S,R)-sulfoximine. Cancer research, 1989, May-01, Volume: 49, Issue:9 Topics: Buthionine Sulfoximine; Cell Cycle; Cell Survival; Glutathione; Humans; Levodopa; Melanoma; Methionine Sulfoximine; Tumor Cells, Cultured	1989
Nigrostriatal dopaminergic neurons remain undamaged in rats given high doses of L-DOPA and carbidopa chronically. Journal of neurochemistry, 1984, Volume: 43, Issue:4 Topics: Animals; Buthionine Sulfoximine; Carbidopa; Corpus Striatum; Dopamine; Female; Glutathione; Levodopa; Methionine Sulfoximine; Neurons; Rats; Rats, Inbred Strains; Substantia Nigra; Tyrosine 3-Monooxygenase	1984
Toxic and protective effects of L-dopa on mesencephalic cell cultures. Journal of neurochemistry, 1993, Volume: 61, Issue:4 Topics: Animals; Buthionine Sulfoximine; Cell Survival; Cells, Cultured; Dopamine; Glutathione; Levodopa; Mesencephalon; Methionine Sulfoximine; Neurons	1993
L-DOPA and glia-conditioned medium have additive effects on tyrosine hydroxylase expression in human catecholamine-rich neuroblastoma NB69 cells. Journal of neurochemistry, 2001, Volume: 78, Issue:3 Topics: Antioxidants; Apoptosis; Ascorbic Acid; bcl-X Protein; Buthionine Sulfoximine; Carbidopa; Cell Differentiation; Culture Media, Conditioned; Culture Media, Serum-Free; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glutathione; Humans; Immunoblotting; Immunohistochemistry; In Situ Nick-End Labeling; Levodopa; Neuroblastoma; Neuroglia; Neurons; Proto-Oncogene Proteins c-bcl-2; Time Factors; Tumor Cells, Cultured; Tyrosine 3-Monooxygenase	2001
Differential effects of l-DOPA on monoamine metabolism, cell survival and glutathione production in midbrain neuronal-enriched cultures from parkin knockout and wild-type mice. Journal of neurochemistry, 2005, Volume: 94, Issue:4 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antimetabolites; Antiparkinson Agents; Apoptosis; Biogenic Monoamines; Buthionine Sulfoximine; Cell Survival; Cells, Cultured; Dopamine; Embryo, Mammalian; Glutathione; Levodopa; MAP Kinase Signaling System; Mesencephalon; Mice; Mice, Knockout; Neurons; Phosphatidylinositol 3-Kinases; Signal Transduction; Ubiquitin-Protein Ligases	2005
Buthionine sulfoximine diverts the melanogenesis pathway toward the production of more soluble and degradable pigments. Bioorganic & medicinal chemistry letters, 2014, May-01, Volume: 24, Issue:9 Topics: Antimetabolites; Buthionine Sulfoximine; Dipeptides; Glutamate-Cysteine Ligase; Glutathione; Levodopa; Melanins	2014